Marisa Dematteo-Santa
Foot & Ankle Surgery · Norwalk, CTNPI 1184809253
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for foot & ankle surgery clinicians in CT, where the typical reported total is $1,838.
Across 66 payments — averaging $21.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$305
- Stryker$267
- Organogenesis Inc.$144
- Paratek Pharmaceuticals, Inc.$135
- Medtronic$96
- Melinta Therapeutics, LLC$82
- plus $414 from 14 others
What the payments were for
- Food & beverage$1,444100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 19 | $305 |
| Stryker(2 entities) | 5 | $267 |
| Organogenesis Inc. | 7 | $144 |
| Paratek Pharmaceuticals, Inc. | 8 | $135 |
| Medtronic | 2 | $96 |
| Melinta Therapeutics, LLC | 5 | $82 |
| Kerecis Limited | 3 | $61 |
| Merck | 3 | $53 |
| Orthofix Medical, Inc. | 1 | $48 |
| Bioventus LLC | 2 | $37 |
| DJO, LLC | 1 | $33 |
| Integra Lifesciences Corporation | 1 | $32 |
| Averitas Pharma Inc. | 1 | $25 |
| GSK | 1 | $25 |
| Sebela Pharmaceuticals Inc. | 2 | $25 |
| Fidia Pharma USA Inc. | 1 | $19 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $15 |
| Next Science LLC | 1 | $15 |
| Osiris Therapeutics Inc. | 1 | $15 |
| Arthrosurface Incorporated | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,444 in reported general payments places this provider in the 40th percentile of 89 foot & ankle surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 111 | $1,691 |
| Ciclopirox | 16 | $583 |
| Cefadroxil | 29 | $182 |
| Doxycycline Hyclate | 18 | $135 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $134 |
| Gabapentin | 14 | $108 |
| Fluconazole | 26 | $43 |
| Mupirocin | 11 | $28 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Norwalk
- Jossie AbrahamNorwalk$152K
- Paulina PiekarskaNorwalk$13K
- Harris GreenbergerNorwalk$3K
- Thomas McDonaldEnfield$241K
- Gabriel GambardellaBloomfield$99K
- David CaminearHamden$47K
- James DejesusNaugatuck$40K
- William ProbascoFairfield$26K
- Adebola AdelekeMiddletown$24K
- Rachel AlbrightDarien$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.